Interferon-γ orchestrates leptomeningeal anti-tumour response.

TitleInterferon-γ orchestrates leptomeningeal anti-tumour response.
Publication TypeJournal Article
Year of Publication2025
AuthorsRemsik J, Tong X, Kunes RZ, Li MJun, Estrera R, Snyder J, Thomson C, Osman AM, Chabot K, Sener UT, Wilcox JA, Isakov D, Wang H, Bale TA, Chaligne R, Sun JC, Brown C, Pe'er D, Boire A
JournalNature
Volume643
Issue8073
Pagination1087-1096
Date Published2025 Jul
ISSN1476-4687
KeywordsAnimals, Breast Neoplasms, Cell Proliferation, Dendritic Cells, Disease Models, Animal, Female, Humans, Interferon-gamma, Killer Cells, Natural, Lung Neoplasms, Male, Melanoma, Meningeal Neoplasms, Meninges, Mice, Mice, Inbred C57BL, Mice, Transgenic, Myeloid Cells, Receptors, CCR7, Receptors, Interferon, Signal Transduction, T-Lymphocytes
Abstract

Metastasis to the cerebrospinal-fluid-filled leptomeninges, or leptomeningeal metastasis, represents a fatal complication of solid tumours1. Multimodal analyses of clinical specimens reveal substantial inflammatory infiltrate in leptomeningeal metastases with enrichment of IFNγ and resulting downstream signalling. Here, to investigate and overcome this futile anti-tumour response within the leptomeninges, we developed syngeneic lung cancer, breast cancer and melanoma leptomeningeal-metastasis mouse models. We show that transgenic host mice lacking IFNγ or its receptor fail to control the growth of leptomeningeal metastases growth. Leptomeningeal overexpression of Ifng through a targeted adeno-associated-virus-based system controls cancer cell growth independent of adaptive immunity. Using a suite of transgenic hosts, we demonstrate that leptomeningeal T cells generate IFNγ to actively recruit and activate peripheral myeloid cells, generating a diverse spectrum of dendritic cell subsets. Independent of antigen presentation, migratory CCR7+ dendritic cells orchestrate the influx, proliferation and cytotoxic action of natural killer cells to control cancer cell growth in the leptomeninges. This study identifies unique, leptomeninges-specific IFNγ signalling and suggests an immune-therapeutic approach against tumours within this space.

DOI10.1038/s41586-025-09012-z
Alternate JournalNature
PubMed ID40369076
PubMed Central IDPMC12286854
Grant ListP30 CA008748 / CA / NCI NIH HHS / United States
R01 CA245499 / CA / NCI NIH HHS / United States
R01 CA300788 / CA / NCI NIH HHS / United States

Person Type: